University of Texas at El Paso
El Paso, Texas, 79968, United States
Location status: Recruiting
Location contact
Jehu N Apaflo, MS
SUB_INVESTIGATOR
Sudip Bajpeyi, PhD
CONTACT
Zahra Fatahimeiabadi, B.S.
SUB_INVESTIGATOR
NCT Number: NCT06722391
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
El Paso, Texas, 79968, United States
Location status: Recruiting
Jehu N Apaflo, MS
SUB_INVESTIGATOR
Sudip Bajpeyi, PhD
CONTACT
Zahra Fatahimeiabadi, B.S.
SUB_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group will receive Electrical Stimulation up to sensory level
Other names: Control
Group will receive Electrical Stimulation up to maximum tolerable level
Other names: NMES Group
Group will receive exercise training.
Other names: Control
Time frame: 8 weeks
Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test and Continuous Glucose Monitoring
Time frame: 8 Weeks
Respiratory Exchange Ratio will be used to quantify substrate utilization (fats vs carbohydrates) through the use of indirect calorimetry of in vivo gas exchange
Time frame: 8 weeks
Amount of lean mass will be measured by dual energy x-ray absortiometry
Contact information is provided by the study sponsor or research team.
University of Texas, El Paso
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724522
Body Weight, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05933707
Body Weight, Body Weight Changes
St Louis, Missouri, United States
View Trial DetailsNCT07690163
Body Weight, Diabetes Mellitus
Kyiv, Ukraine
View Trial DetailsNCT07703371
Body Weight, Dyslipidemia
Mysore, Karnataka, India
View Trial Details